These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7334461)

  • 41. Pharmacokinetics of TH-302: a hypoxically activated prodrug of bromo-isophosphoramide mustard in mice, rats, dogs and monkeys.
    Jung D; Lin L; Jiao H; Cai X; Duan JX; Matteucci M
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):643-54. PubMed ID: 21964906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clearance studies of methotrexate in dogs after multiple-rate infusion.
    Lui CY; Lee MG; Chiou WL
    Cancer Res; 1985 Apr; 45(4):1545-8. PubMed ID: 3978622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absorption, elimination and cerebrospinal fluid concentrations of nimodipine in healthy beagle dogs receiving human intravenous and oral formulation.
    Koskimäki J; Tarkia M; Ahtola-Sätilä T; Saloranta L; Laakso A; Frantzén J
    Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):295-300. PubMed ID: 25652785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. D-penicillamine in patients with rheumatoid arthritis. Serum levels, pharmacokinetic aspects, and correlation with clinical course and side effects.
    Muijsers AO; van de Stadt RJ; Henrichs AM; Ament HJ; van der Korst JK
    Arthritis Rheum; 1984 Dec; 27(12):1362-9. PubMed ID: 6508861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of defibrotide in healthy volunteers.
    Noseda G; Fragiacomo C; Ferrari D
    Haemostasis; 1986; 16 Suppl 1():26-30. PubMed ID: 3754833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of heparin. II. Studies of time dependence in rats.
    Bjornsson TD; Levy G
    J Pharmacol Exp Ther; 1979 Aug; 210(2):243-6. PubMed ID: 458631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of ketorolac after intravenous and oral single dose administration in dogs.
    Pasloske K; Renaud R; Burger J; Conlon P
    J Vet Pharmacol Ther; 1999 Oct; 22(5):314-9. PubMed ID: 10597535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of the duration of infusion on the disposition of lidocaine in dogs.
    LeLorier J; Moisan R; Gagné J; Caillé G
    J Pharmacol Exp Ther; 1977 Dec; 203(3):507-11. PubMed ID: 925956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of food on the intravenous and oral dose kinetics of propranolol in the dog.
    Bai SA; Walle UK; Walle T
    J Pharmacokinet Biopharm; 1985 Jun; 13(3):229-41. PubMed ID: 4087163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats.
    Egorin MJ; Yuan ZM; Sentz DL; Plaisance K; Eiseman JL
    Cancer Chemother Pharmacol; 1999; 43(6):445-53. PubMed ID: 10321503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of N-nitrosodimethylamine in beagles.
    Gombar CT; Pylypiw HM; Harrington GW
    Cancer Res; 1987 Jan; 47(2):343-7. PubMed ID: 3791224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemodynamic, electrocardiographic, electrophysiologic and pharmacokinetic activity of 4'-hydroxypropranolol in dogs.
    Muir WW; Sams RA; Schall SF
    J Vet Pharmacol Ther; 1996 Aug; 19(4):259-67. PubMed ID: 8866453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.
    Ings RM; Reeves DS; White LO; Bax RP; Bywater MJ; Holt HA
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):121-42. PubMed ID: 4057054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
    Vinayek R; Amantea MA; Maton PN; Frucht H; Gardner JD; Jensen RT
    Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.
    Kleinbloesem CH; van Brummelen P; van Harten J; Danhof M; Breimer DD
    Clin Pharmacol Ther; 1985 May; 37(5):563-74. PubMed ID: 3987180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Kolstad IM; Johnsen S
    Eur J Clin Microbiol; 1986 Apr; 5(2):187-92. PubMed ID: 2941278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of different dosing schedules of UCN-01 on its pharmacokinetics and cardiohaemodynamics in dogs.
    Kurata N; Imabeppu S; Nitoh M; Kobayashi H; Kuwabara T; Kobayashi S
    J Pharm Pharmacol; 2000 Nov; 52(11):1327-35. PubMed ID: 11186240
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioavailability and pharmacokinetics of D-penicillamine.
    Kukovetz WR; Beubler E; Kreuzig F; Moritz AJ; Nirnberger G; Werner-Breitenecker L
    J Rheumatol; 1983 Feb; 10(1):90-4. PubMed ID: 6842492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.